Molecule Name |
DB00206
|
DrugBank Groups |
Approved
|
Cluster No |
73
|
Smiles |
O=C(OC2(C(OC)C(C(=O)OC)C3(CC4(C=1(NC=5(C=C(OC)C=CC=5(C=1CCN4(CC3(C2)))))))))C6(=CC(OC)=C(OC)C(=C6)OC)
|
Download |
mol2, pdbqt
|
TPSA |
117,78
|
Non-H Atoms |
44
|
Non-C/H Atoms |
11
|
Metal-Atoms |
0
|
Electronegative Atoms |
11
|
Stereo Centers |
6
|
Rotatable Bonds |
10
|
Rings Closures |
6
|
Small Rings |
6
|
Aromatic Rings |
3
|
Aromatic Atoms |
15
|
sp3-Atoms |
25
|
Symmetric atoms |
4
|
cLogS |
-4,446
|
MW |
608,686
|
cLogP |
3,5754
|
HBA |
11
|
HBD |
1
|
Ro5 violations |
2
|
Druglikeness |
2,322
|
DrugScore |
0,25674937496717
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
high
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Inhibitor
|
Aqueous solubility |
-2,6738
|
Caco-2 Permeability 2 |
1,103
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,2009
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,3971
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
II
|
Rat Acute Toxicity (LD50, mol/kg) |
3,1297
|
Carcinogenicity (Three-class) |
Non-required
|